Aparna Biosciences Overview
- Founded
-
2007
- Status
-
Out of Business
- Employees
-
4
- Latest Deal Type
-
Out of Business
Aparna Biosciences General Information
Description
Developer of biomedical nanoparticle technology and products for research and treatment of human disease. The company develops tissue targeting technology platforms that can advance biomedical research and ultimately revolutionary therapeutics.
Contact Information
Website
www.aparnabio.com
Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
- 12111 Parklawn Drive
- Suite 123
- Rockville, MD 20852
- United States
Aparna Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 01-Oct-2017 | Completed | Out of Business | |||
| 2. Accelerator/Incubator | 10-Aug-2011 | Completed | Startup | |||
| 1. Grant | 01-Sep-2009 | $1.44M | Completed | Startup |
Aparna Biosciences Patents
Aparna Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-2257280-A1 | Engineered tunable nanoparticles for delivery of therapeutics, diagnostics, and experimental compounds and related compositions for therapeutic use | Withdrawn | 26-Feb-2008 | 00000000 | |
| US-20110312877-A1 | Engineered tunable nanoparticles for delivery of therapeutics, diagnostics, and experimental compounds and related compositions for therapeutic use | Abandoned | 26-Feb-2008 | 00000000 | 0 |
| EP-2257280-A4 | Engineered tunable nanoparticles for delivery of therapeutics, diagnostics, and experimental compounds and related compositions for therapeutic use | Withdrawn | 26-Feb-2008 | 00000000 | 0 |
| US-9095568-B2 | Therapeutic and vaccine polyelectrolyte nanoparticle compositions | Expired - Fee Related | 26-Sep-2007 | 0000000000 | 0 |
| EP-2197457-A4 | Therapeutic and vaccine polyelectrolyte nanoparticle compositions | Withdrawn | 26-Sep-2007 | A61K31/575 | 0 |
Aparna Biosciences Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Martin Woodle Ph.D | Co-Founder & Chief Executive and Scientific Officer | ||
| Puthupparampil Scaria Ph.D | Co-Founder & Vice President, Research & Development |
Aparna Biosciences Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
